Vesa Manninen

14.3k total citations · 4 hit papers
144 papers, 11.2k citations indexed

About

Vesa Manninen is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Vesa Manninen has authored 144 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 45 papers in Endocrinology, Diabetes and Metabolism and 33 papers in Surgery. Recurrent topics in Vesa Manninen's work include Lipoproteins and Cardiovascular Health (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Hormonal Regulation and Hypertension (15 papers). Vesa Manninen is often cited by papers focused on Lipoproteins and Cardiovascular Health (19 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (16 papers) and Hormonal Regulation and Hypertension (15 papers). Vesa Manninen collaborates with scholars based in Finland, United States and Russia. Vesa Manninen's co-authors include Matti Mänttäri, Jussi K. Huttunen, M. H. Frick, Pekka Koskinen, Leena Tenkanen, Olli P. Heinonen, Marjatta Mälkönen, Matti Romo, J Pikkarainen and Hanna Mäenpää and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Vesa Manninen

142 papers receiving 10.4k citations

Hit Papers

Helsinki Heart Study: Primary-Prevention Trial with Gemfi... 1987 2026 2000 2013 1987 1992 1988 1992 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
    1987 2.9k citations M. H. Frick, Olli P. Heinonen et al. profile →
  2. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
    1992 1.1k citations Vesa Manninen, Leena Tenkanen et al. Circulation profile →
  3. Lipid Alterations and Decline in the Incidence of Coronary Heart Disease in the Helsinki Heart Study
    1988 770 citations Vesa Manninen profile →
  4. Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study
    1992 636 citations Leena Tenkanen, Vesa Manninen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vesa Manninen Finland 39 5.0k 4.8k 2.7k 1.4k 1.4k 144 11.2k
Matti Mänttäri Finland 33 4.1k 0.8× 3.6k 0.8× 2.3k 0.8× 1.1k 0.8× 1.2k 0.9× 59 8.7k
M. H. Frick Finland 34 4.3k 0.9× 3.5k 0.7× 2.5k 0.9× 1.1k 0.8× 967 0.7× 106 8.6k
Jussi K. Huttunen Finland 59 5.2k 1.0× 5.2k 1.1× 2.7k 1.0× 2.5k 1.8× 2.1k 1.6× 165 17.6k
Peter O. Kwiterovich United States 54 6.4k 1.3× 4.7k 1.0× 2.3k 0.8× 2.0k 1.4× 1.0k 0.8× 195 11.7k
Jiří Fröhlich Canada 51 4.8k 1.0× 3.8k 0.8× 2.3k 0.9× 1.4k 1.0× 1.3k 1.0× 166 10.2k
D. J. Betteridge United Kingdom 42 3.5k 0.7× 4.3k 0.9× 2.3k 0.9× 1.6k 1.1× 1.0k 0.8× 144 9.8k
Russell Scott New Zealand 45 4.8k 1.0× 5.9k 1.2× 1.9k 0.7× 2.7k 1.9× 1.2k 0.8× 235 11.4k
Sander J. Robins United States 46 5.4k 1.1× 4.9k 1.0× 2.8k 1.0× 2.3k 1.6× 2.1k 1.5× 101 12.5k
Robert H. Knopp United States 68 6.1k 1.2× 6.2k 1.3× 2.5k 0.9× 1.7k 1.2× 2.7k 2.0× 229 18.1k
John J. Albers United States 65 8.1k 1.6× 6.7k 1.4× 2.9k 1.1× 2.7k 1.9× 1.8k 1.3× 201 14.9k

Countries citing papers authored by Vesa Manninen

Since Specialization
Citations

This map shows the geographic impact of Vesa Manninen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vesa Manninen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vesa Manninen more than expected).

Fields of papers citing papers by Vesa Manninen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vesa Manninen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vesa Manninen. The network helps show where Vesa Manninen may publish in the future.

Co-authorship network of co-authors of Vesa Manninen

This figure shows the co-authorship network connecting the top 25 collaborators of Vesa Manninen. A scholar is included among the top collaborators of Vesa Manninen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vesa Manninen. Vesa Manninen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tenkanen, Leena, Matti Mänttäri, Petri T. Kovanen, Hanna Virkkunen, & Vesa Manninen. (2006). Gemfibrozil in the Treatment of Dyslipidemia. Archives of Internal Medicine. 166(7). 743–743. 94 indexed citations
2.
Golomb, Beatrice A., et al.. (2002). Insulin sensitivity markers. Journal of Clinical Epidemiology. 55(8). 767–773. 55 indexed citations
3.
Kovanen, Petri T., Matti Mänttäri, Timo Palosuo, Vesa Manninen, & Kimmo Aho. (1998). Prediction of Myocardial Infarction in Dyslipidemic Men by Elevated Levels of Immunoglobulin Classes A, E, and G, but Not M. Archives of Internal Medicine. 158(13). 1434–1434. 87 indexed citations
4.
Syvänne, Mikko, Marja‐Riitta Taskinen, Markku S. Nieminen, et al.. (1997). A study to determine the response of coronary atherosclerosis to raising low high density lipoprotein cholesterol with a fibric-acid derivative in men after coronary bypass surgery. Controlled Clinical Trials. 18(1). 93–119. 20 indexed citations
5.
Mänttäri, Matti, Vesa Manninen, Timo Palosuo, et al.. (1994). Serum ferritin and ceruloplasmin as coronary risk factors. European Heart Journal. 15(12). 1599–1603. 110 indexed citations
6.
Karjalainen, Jouko, Matti Viitasalo, Matti Mänttäri, & Vesa Manninen. (1994). Relation between QT intervals and heart rates from 40 to 120 beats/min in rest electrocardiograms of men and a simple method to adjust QT interval values. Journal of the American College of Cardiology. 23(7). 1547–1553. 223 indexed citations
7.
Arvola, Pertti, Mika Kähönen, Heikki Mäkynen, et al.. (1993). High Calcium Diet, Different Antihypertensive Agents, and Cytosolic Free Ca2+ in Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 22(5). 702–705. 7 indexed citations
8.
Mänttäri, Matti, Leena Tenkanen, Hanna Mäenpää, Vesa Manninen, & Jussi K. Huttunen. (1993). High-density lipoprotein cholesterol elevation with gemfibrozil: Effects of baseline level and modifying factors. Clinical Pharmacology & Therapeutics. 54(4). 437–447. 6 indexed citations
9.
Toivonen, L., et al.. (1992). Hemodynamic effects of bevantolol and propranolol at rest and during isometric exercise in healthy subjects. Current Therapeutic Research. 51(4). 536–545. 1 indexed citations
10.
Manninen, Vesa, Leena Tenkanen, Pekka Koskinen, et al.. (1992). Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Circulation. 85. 37–45. 312 indexed citations
11.
Hautanen, Aarno, Matti Mänttäri, Vesa Manninen, M. H. Frick, & Herman Adlercreutz. (1992). Effects of gemfibrozil treatment on serum levels of androstanediol glucuronide and adrenal androgens. The Journal of Steroid Biochemistry and Molecular Biology. 42(3-4). 433–434. 6 indexed citations
12.
Heliö, Tiina, E H Ludwig, Aarno Palotie, et al.. (1991). Apolipoprotein B gene 3'hypervariable region polymorphism and myocardial infarction in dyslipidemic Finnish men participating in a primary prevention trial. Nutrition Metabolism and Cardiovascular Diseases. 1. 178–182. 5 indexed citations
13.
Laustiola, K., et al.. (1991). Exogenous GTP Enhances the Effects of Sodium Nitrite on Cyclic GMP Accumulation, Vascular Smooth Muscle Relaxation and Platelet Aggregation. Pharmacology & Toxicology. 68(1). 60–63. 32 indexed citations
14.
Vuorinen, Pauli, et al.. (1991). Modification of Nitrovasodilator Effects on Vascular Smooth Muscle by Exogenous GTP and Guanosine. Journal of Cardiovascular Pharmacology. 18(6). 871–877. 7 indexed citations
15.
Laustiola, K., et al.. (1991). Cigarette Smoking Alters Sympathoadrenal Regulation by Decreasing the Density of β2-Adrenoceptors. A Study of Monitored Smoking Cessation. Journal of Cardiovascular Pharmacology. 17(6). 923–928. 35 indexed citations
16.
Mänttäri, Matti, Pekka Koskinen, Vesa Manninen, Leena Tenkanen, & Jussi K. Huttunen. (1991). Lifestyle determinants of HDL2- and HDL3-cholesterol levels in a hypercholesterolemic male population. Atherosclerosis. 87(1). 1–8. 4 indexed citations
17.
Mänttäri, Matti, Jussi K. Huttunen, Pekka Koskinen, et al.. (1990). Lipoproteins and coronary heart disease in the Helsinki Heart Study. European Heart Journal. 11(suppl H). 26–31. 33 indexed citations
18.
19.
Mänttäri, Matti, Pekka Koskinen, Vesa Manninen, et al.. (1990). Effect of gemfibrozil on the concentration and composition of serum lipoproteins A controlled study with special reference to initial triglyceride levels. Atherosclerosis. 81(1). 11–17. 33 indexed citations
20.
Mäenpää, Heikki, Vesa Manninen, & O. P. Heinonen. (1987). Comparison of the digoxin marker with capsule counting and compliance questionnaire methods for measuring compliance to medication in a clinical trial. European Heart Journal. 8(suppl I). 39–43. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matti Mänttäri Breakdown of academic impact, for papers by M. H. Frick Breakdown of academic impact, for papers by Jussi K. Huttunen Breakdown of academic impact, for papers by Peter O. Kwiterovich Breakdown of academic impact, for papers by Jiří Fröhlich Breakdown of academic impact, for papers by D. J. Betteridge Breakdown of academic impact, for papers by Russell Scott Breakdown of academic impact, for papers by Sander J. Robins Breakdown of academic impact, for papers by Robert H. Knopp Breakdown of academic impact, for papers by John J. Albers
Rankless by CCL
2026